ArticleJournal of perinatology : official journal of the California Perinatal Association2026
Hyperbilirubinemia in premature infants <35 weeks' gestation: A chronologic age format for graphing consensus-based recommendations.
Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAt the request of the AAP, consensus-based recommendations for managing hyperbilirubinemia in infants < 35 weeks' postmenstrual age (PMA) were published in 2012. Subsequently, a PMA-based graphical format of these recommendations was popularized as Premie BiliRecs, providing decision support for infants ≥ 27 weeks' PMA and ≥ 48 h old.
methodsChronologic age-based guidelines based on gestational age (GA) at birth were derived from the consensus-based recommendations and modified with integration of the AAP hyperbilirubinemia guidelines and extension of decision support for a minimum of 14 days. These guidelines were implemented in an electronic medical record.
resultsThe modified consensus guidelines provide support from birth for all infants < 35 weeks' GA and address limitations of the current graphical tools. An interactive tool illustrating these guidelines is available at https://bilirubin-guidelines.net . (Contact your institutional IT department if access to the website is blocked).
conclusionsThese modified consensus guidelines expand decision support for infants < 35 weeks' GA with a format harmonized with the AAP graphs.
Indexed as
Identifiers
42642492What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.